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OBJECTIVE — To identify type 1 diabetes–susceptible HLA DR-DQ haplotypes using tag
single nucleotide polymorphisms (SNPs) and to estimate the disease risk using these tag SNPs.
RESEARCH DESIGN AND METHODS — Five tag SNPs were typed in a total of 211
Japanese subjects including 201 patients with type 1 diabetes who had already been typed for
HLA-DRB1, -DQA1, and -DQB1 alleles and 300 control subjects.
RESULTS — Tag SNP rs2395185 captured haplotypes involving all DR4 speciﬁcities and DR9
speciﬁcity with a sensitivity of 98.5% and speciﬁcity of 94.9%. Using the T allele of rs2395185, we
obtained an odds ratio (95% CI) of 2.87 (2.21–3.74) for type 1 diabetes. In addition, rs3129888
capturedhaplotypesinvolvingHLA-DRB1*0802withasensitivityof92.3%andspeciﬁcityof98.9%.
CONCLUSIONS — Typing of two tag SNPs (rs2395185 and rs3129888) may be useful for
the screening of Japanese subjects at genetic risk of type 1 diabetes.
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A
lthough the major histocompatibil-
ity complex class II region confers
susceptibility to type 1 diabetes
most strongly (1), DNA typing of the
HLA-DR and -DQ alleles is complicated.
Weattemptedtoidentifytype1diabetes–
susceptible HLA DR-DQ haplotypes rap-
idly using tag single nucleotide
polymorphisms (SNPs) and further esti-
mated the disease risk using these tag
SNPs.
RESEARCH DESIGN AND
METHODS— The tag SNPs for HLA
class II alleles were typed in a total of 211
subjects including 201 patients with type
1 diabetes (115 male subjects and 86 fe-
male subjects; mean  SD age at onset
3414years)and10patientswithother
diseases (one patient with type 2 diabetes
and nine patients with chronic hepatitis
C) who had already been typed for HLA-
DRB1, -DQA1, and -DQB1 alleles (2–4)
and 300 control subjects (231 male sub-
jects and 69 female subjects).
Based on the study by de Bakker et al.
(5), we chose rs2395185 (T) and rs411326
(C) for HLA-DRB1*0405, rs3129888 (G)
for HLA-DRB1*0802, rs6457617 (T) for
HLA-DQA1*03, and rs3998159 (A) for
HLA-DQB1*0303 as the tag SNPs. These
SNPsweregenotypedusingTaqManAssays
(AppliedBiosystems,FosterCity,CA).This
study was approved by the Committee for
InvestigationsInvolvingHumanSubjectsof
Toranomon Hospital.
We performed two-by-two contin-
gency analysis (Fisher exact probability
test) and determined the sensitivity and
speciﬁcity of tag SNPs for identifying spe-
ciﬁc DRB1-DQA1-DQB1 haplotypes. In
the case-control study, the odds ratios
(ORs) for developing type 1 diabetes and
the 95% CIs were calculated by logistic
regression.
RESULTS— As for rs2395185, all (18/
18) subjects who had two copies of haplo-
types involving DRB1*0405, which were
referred to as haplogenotype 0405/0405,
had the TT genotype. Only 64.1% (59/92)
of the subjects who had one copy of the
haplotype involving DRB1*0405 and the
other copy of the haplotype not involving
DRB1*0405 (referred to as haplogenotype
0405/X) had the GT genotype, and only
23.8% (24/101) of the subjects who had
two copies of haplotypes not involving
DRB1*0405 (referred to as haplogenotype
X/X) had the GG genotype (Fig. 1A). The
sensitivity for rs2395185 to capture haplo-
types involving DRB1*0405 was 98.4%
(125/128), but the speciﬁcity was only
51.0% (150/294). However, interestingly,
in the subjects with genotype TT of
rs2395185 and haplogenotype 0405/X, all
(31/31) X haplotypes corresponded to
those involving DR4 or DR9 speciﬁcities
(Fig. 1A). Here, DR4 speciﬁcities included
DRB1*0401, 0403, 0404, 0405, 0406,
0407, and DR9 speciﬁcity included
DRB1*0901. Furthermore, in the subjects
with genotype TT of rs2395185 and hap-
logenotype X/X, 97% (70/72) of the T al-
leles of rs2395185 linked up with
haplotypes involving DR4 or DR9 speciﬁc-
ities (Fig. 1A). In contrast, in the subjects
with genotype GG of rs2395185 and hap-
logenotypeX/X,98%(47/48)oftheGallele
of rs2395185 linked up with haplotypes
notinvolvingDR4orDR9speciﬁcities(Fig.
1A).Givensuchanallocationofrs2395185
to DR4 or DR9 speciﬁcities, in the subjects
with the GT genotype of rs2395185 and
haplogenotype X/X, 88% (36/41) of the T
allele of rs2395185 linked up with haplo-
types involving DR4 or DR9 speciﬁcities.
Thus, in all subjects analyzed, rs2395185
captured haplotypes involving all DR4
speciﬁcities and DR9 speciﬁcity with a sen-
sitivity of 98.5% (262/266) and speciﬁcity
of 94.9% (148/156) (P  0.0001) (supple-
mental Fig. 1, available in an online appen-
dix at http://care.diabetesjournals.org/cgi/
content/full/dc09-1210/DC1).
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ing DRB1*0802 had G allele of rs3129888
(sensitivity 92.3%), and 390 of 394 haplo-
types not involving DRB1*0802 had A al-
lele of rs3129888 (speciﬁcity 98.9%) (P 
0.0001) (Fig. 1B).
As for the remaining tag SNPs, sensi-
tivities for tagging corresponding HLA al-
leles were high (90%), but speciﬁcities
were not adequate (17.4–64.4%) (sup-
plemental Fig. 2). Unlike rs2395185,
rs411326 could not capture haplotypes
involving DR4 or DR9 speciﬁcities (sensi-
tivity 69.3% and speciﬁcity 74.3%) (sup-
plemental Fig. 2A).
Using the T allele of rs2395185, we
obtainedOR2.87(95%CI2.21–3.74)for
type 1 diabetes. The ORs for type 1 dia-
betes in the GT genotype or the TT ge-
notype of rs2395185 were 2.72 (1.65–
4.62) or 9.49 (5.37–17.3), respectively.
On the other hand, the distribution of
alleles or genotypes of rs3129888 did
not differ between patients with type 1
diabetes and control subjects (supple-
mental Table 1).
CONCLUSIONS — Capture of hap-
lotypes involving all DR4 speciﬁcities and
DR9speciﬁcitybyrs2395185maybedue
to the involvement of both DR4 and DR9
in the DR53-asociated antigens (6). The
haplotypesthatrs2395185capturedwere
DRB1*0405-DQA1*03-DQB1*0401,
0402, or 0302, DRB1*0403, 0404, 0406,
or 0407-DQA1*03-DQB1*0302, and
DRB1*0901-DQA1*03-DQB1*0303
(supplemental Fig. 1). In addition to the
haplotypes of DRB1*0405-DQA1*03-
DQB1*0401 and DRB1*0901-DQA1*03-
DQB1*0303 (7–10), the haplotype of
DRB1*0405-DQA1*03-DQB1*0402
andDRB1*0405-DQA1*03-DQB1*0302
also indicates susceptibility in the Japa-
nese subjects (9,10). Although the hap-
lotypes of DRB1*04-DQA1*03-
DQB1*0302 were neutral or protective
whenDRB1*04wasotherthan*0405(7–
9), these haplotypes, especially
DRB1*0403 or 0406-DQA1*03-
DQB1*0302, formed the susceptible
DR3/4-DQB1*0302 genotype in Korean
and Taiwanese subjects (11). The hap-
lotype of DRB1*0401-DQA1*03-
DQB1*0301didnotproducesusceptibility
(7,8), but the frequency of these haplo-
types was relatively low (1.13%) (12).
Thus, rs2395185 was able to capture all
type 1 diabetes–susceptible or potentially
susceptible DR-DQ haplotypes except for
DRB1*0802-DQA1*03-DQB1*0302 (7–
8). In fact, the T allele of rs2395185 pro-
videdahighOR(2.87)fortheriskoftype
1 diabetes, which was almost equivalent
to that of haplotype of DRB1*0405-
DQB1*0401 (2.9–3.88) or haplotype of
DRB1*0901-DQB1*0303 (2.54–4.34)
in another study in Japanese subjects (8).
Haplotype of DRB1*0802-DQA1*03-
DQB1*0302 could be captured by
rs3129888. Although, in this study, allele
frequency of DRB1*0802 was less than
that in the previous study (9), it may be
due to older onset age of diabetes in our
patients (8).
In Caucasians, a two-SNP test for
screening the risk genotype DR3/4-DQ8
was reported recently (13). In Japanese
Figure 1—Relationships between genotypes of rs2395185 and haplotype combinations of those
involving HLA-DRB1*0405 (0405) or not (X)( A), and genotypes of rs3129888 and haplotype
combinations of those involving HLA-DRB1*0802 (0802) or not (X)( B). In panel A, diagonally
linedportionsinthebarindicatethathaplotypeX(oneofXhaplotypesinthecaseofX/X)involves
DR4orDR9,andtheportioncoloredblackinthebarindicatesthathaplogenotypeX/Xconsistsof
two copies of haplotypes involving DR4 or DR9.
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rs3129888 captured different susceptible
DR-DQ haplotypes. Therefore, simulta-
neous typing of these two SNPs will facil-
itate the screening of subjects at risk for
type 1 diabetes in the Japanese popula-
tion, especially in the patients with type 2
diabetes because 10% of them are pos-
itive for at least one autoantibody to islet
cells and progress to an insulin-
dependent state (slowly progressive type
1 diabetes) (14).
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